HIV Vaccine Trials: FDA Mulls Ethics Of Enrolling Teens; Is Phase II Too Soon?

The first approved HIV vaccine should be initially indicated for both adolescent and adult populations, but how and when to enroll adolescents in clinical trials is less straightforward, FDA's Pediatric Ethics Subcommittee determined at a June 9 meeting